Cargando…
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers
In the past decade, aberrant O-GlcNAcylation has emerged as a new hallmark of cancer. O-GlcNAcylation is a post-translational modification that results when the amino-sugar β-D-N-acetylglucosamine (GlcNAc) is made in the hexosamine biosynthesis pathway (HBP) and covalently attached to serine and thr...
Autor principal: | Spaner, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639227/ https://www.ncbi.nlm.nih.gov/pubmed/34868034 http://dx.doi.org/10.3389/fimmu.2021.772304 |
Ejemplares similares
-
O-GlcNAcylation and Its Role in Cancer-Associated Inflammation
por: Ouyang, Muzi, et al.
Publicado: (2022) -
Mass Spectrometry for O-GlcNAcylation
por: Yin, Ruoting, et al.
Publicado: (2021) -
The role of O-GlcNAcylation in development
por: Czajewski, Ignacy, et al.
Publicado: (2023) -
O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis
por: Seo, Junghwa, et al.
Publicado: (2023) -
Protein O-GlcNAcylation Regulates Innate Immune Cell Function
por: Dong, Hong, et al.
Publicado: (2022)